InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Chess Master post# 3142

Saturday, 06/10/2017 6:04:33 AM

Saturday, June 10, 2017 6:04:33 AM

Post# of 3833
No matter what - they will need a partner.

If the drug shows good results in this trial - BP will need them and other pipeline products may not matter as BP will just buy them

(See Anacor was bought by Pfizer for $5.2 B. Compared to that NASH is very promising area with clear unmet demands and no available treatments.

Even if they decide to go alone - it will be tough - look at ACAD - without a BP partner - they are struggling in marketing the product and absorbing marketing cost.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News